Pacific Biosciences of California Inc
NASDAQ:PACB

Watchlist Manager
Pacific Biosciences of California Inc Logo
Pacific Biosciences of California Inc
NASDAQ:PACB
Watchlist
Price: 1.47 USD 13.95% Market Closed
Market Cap: $443.9m

Wall St Price Targets

PACB Price Targets Summary
Pacific Biosciences of California Inc

Wall Street analysts forecast PACB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PACB is 2.51 USD with a low forecast of 1.52 USD and a high forecast of 3.15 USD.

Lowest Forecast
Price Target
1.52 USD
3% Upside
Average Forecast
Price Target
2.51 USD
71% Upside
Highest Forecast
Price Target
3.15 USD
114% Upside
Pacific Biosciences of California Inc Competitors:
Price Targets
AAT
American Assets Trust Inc
-17% Downside
DREAMFOLKS
Dreamfolks Services Ltd
80% Upside
MRKR
Marker Therapeutics Inc
431% Upside
SAMG
Silvercrest Asset Management Group Inc
69% Upside

Revenue
Forecast

15% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
15% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 7 years is 22%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-56%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-56%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PACB's stock price target?
Price Target
2.51 USD

According to Wall Street analysts, the average 1-year price target for PACB is 2.51 USD with a low forecast of 1.52 USD and a high forecast of 3.15 USD.

What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
22%

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 7 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett